Berkshire Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $82.8M | Buy |
380,870
+3,922
| +1% | +$870K | 3.55% | 2 |
|
|
2025
Q4 | $86.1M | Sell |
376,948
-3,451
| -0.9% | -$786K | 3.78% | 3 |
|
|
2025
Q3 | $88.1M | Sell |
380,399
-3,428
| -0.9% | -$698K | 3.74% | 3 |
|
|
2025
Q2 | $71.2M | Buy |
383,827
+205
| +0.1% | +$38.1K | 3.23% | 3 |
|
|
2025
Q1 | $71.2M | Sell |
383,622
-4,335
| -1% | -$843K | 3.41% | 3 |
|
|
2024
Q4 | $66.1M | Sell |
387,957
-17,757
| -4% | -$3.26M | 3.12% | 3 |
|
|
2024
Q3 | $69.6M | Hold |
405,714
| – | – | 3.54% | 3 |
|
|
2024
Q2 | $69.6M | Buy |
405,714
+17,404
| +4% | +$2.88M | 3.47% | 3 |
|
|
2024
Q1 | $70.7M | Sell |
388,310
-3,429
| -0.9% | -$591K | 3.74% | 3 |
|
|
2023
Q4 | $60.7M | Sell |
391,739
-429
| -0.1% | -$62.5K | 3.46% | 3 |
|
|
2023
Q3 | $58.5M | Sell |
392,168
-2,822
| -0.7% | -$414K | 3.65% | 4 |
|
|
2023
Q2 | $53.2M | Buy |
394,990
+8,101
| +2% | +$1.19M | 3.16% | 6 |
|
|
2023
Q1 | $61.7M | Sell |
386,889
-2,427
| -0.6% | -$371K | 3.81% | 2 |
|
|
2022
Q4 | $62.9M | Buy |
389,316
+2,600
| +0.7% | +$399K | 4.04% | 2 |
|
|
2022
Q3 | $51.9M | Sell |
386,716
-5,111
| -1% | -$733K | 3.67% | 2 |
|
|
2022
Q2 | $60M | Buy |
391,827
+6,893
| +2% | +$1.05M | 3.92% | 1 |
|
|
2022
Q1 | $62.4M | Buy |
384,934
+3,722
| +1% | +$541K | 3.94% | 2 |
|
|
2021
Q4 | $51.6M | Sell |
381,212
-1,955
| -0.5% | -$231K | 3.14% | 4 |
|
|
2021
Q3 | $41.3M | Buy |
383,167
+8,343
| +2% | +$953K | 2.77% | 6 |
|
|
2021
Q2 | $42.2M | Buy |
374,824
+15,501
| +4% | +$1.75M | 2.85% | 5 |
|
|
2021
Q1 | $38.9M | Sell |
359,323
-13,484
| -4% | -$1.44M | 2.88% | 6 |
|
|
2020
Q4 | $39.9M | Buy |
372,807
+32,702
| +10% | +$3.14M | 3.07% | 4 |
|
|
2020
Q3 | $29.8M | Sell |
340,105
-25,853
| -7% | -$2.43M | 2.88% | 6 |
|
|
2020
Q2 | $35.9M | Buy |
365,958
+12,013
| +3% | +$1.06M | 3.31% | 5 |
|
|
2020
Q1 | $27M | Buy |
353,945
+8,298
| +2% | +$707K | 2.81% | 6 |
|
|
2019
Q4 | $30.6M | Sell |
345,647
-8,033
| -2% | -$667K | 2.6% | 8 |
|
|
2019
Q3 | $26.8M | Sell |
353,680
-17,191
| -5% | -$1.18M | 2.31% | 9 |
|
|
2019
Q2 | $27M | Buy |
370,871
+23,732
| +7% | +$1.87M | 2.23% | 9 |
|
|
2019
Q1 | $28M | Buy |
347,139
+385
| +0.1% | +$31.5K | 2.37% | 6 |
|
|
2018
Q4 | $32M | Sell |
346,754
-292
| -0.1% | -$25.7K | 2.99% | 4 |
|
|
2018
Q3 | $32.8M | Buy |
347,046
+15,748
| +5% | +$1.49M | 2.78% | 3 |
|
|
2018
Q2 | $30.7M | Buy |
331,298
+3,165
| +1% | +$309K | 2.88% | 4 |
|
|
2018
Q1 | $31.1M | Buy |
328,133
+2,983
| +0.9% | +$328K | 3.02% | 4 |
|
|
2017
Q4 | $31.4M | Buy |
325,150
+26,126
| +9% | +$2.46M | 3.05% | 4 |
|
|
2017
Q3 | $26.6M | Sell |
299,024
-2,212
| -0.7% | -$168K | 2.96% | 3 |
|
|
2017
Q2 | $21.8M | Buy |
301,236
+3,431
| +1% | +$231K | 2.49% | 8 |
|
|
2017
Q1 | $19.4M | Buy |
297,805
+11,135
| +4% | +$700K | 2.3% | 10 |
|
|
2016
Q4 | $18M | Buy |
286,670
+18,913
| +7% | +$1.15M | 2.32% | 14 |
|
|
2016
Q3 | $16.9M | Buy |
267,757
+9,295
| +4% | +$602K | 2.43% | 11 |
|
|
2016
Q2 | $16M | Sell |
258,462
-11,856
| -4% | -$722K | 2.43% | 12 |
|
|
2016
Q1 | $15.4M | Buy |
270,318
+6,959
| +3% | +$388K | 2.4% | 13 |
|
|
2015
Q4 | $15.6M | Buy |
263,359
+14,894
| +6% | +$858K | 2.58% | 11 |
|
|
2015
Q3 | $13.5M | Buy |
248,465
+5,686
| +2% | +$370K | 2.41% | 12 |
|
|
2015
Q2 | $16.3M | Sell |
242,779
-402
| -0.2% | -$26.2K | 2.74% | 8 |
|
|
2015
Q1 | $14.2M | Buy |
243,181
+3,946
| +2% | +$238K | 2.38% | 11 |
|
|
2014
Q4 | $15.7M | Buy |
239,235
+6,510
| +3% | +$410K | 2.69% | 6 |
|
|
2014
Q3 | $13.4M | Sell |
232,725
-651
| -0.3% | -$36.1K | 2.48% | 9 |
|
|
2014
Q2 | $13.2M | Sell |
233,376
-9,402
| -4% | -$493K | 2.45% | 9 |
|
|
2014
Q1 | $12.5M | Sell |
242,778
-6,565
| -3% | -$332K | 2.4% | 9 |
|
|
2013
Q4 | $13.2M | Buy |
249,343
+31,453
| +14% | +$1.55M | 2.48% | 8 |
|
|
2013
Q3 | $9.75M | Buy |
217,890
+16,512
| +8% | +$732K | 2.34% | 12 |
|
|
2013
Q2 | $8.32M | Buy |
+201,378
| New | +$8.81M | 2.3% | 14 |
|
Other funds holding ABBV
VCM
VPM
Berkshire Asset Management's ABBV Position: Q1 2026 in Review
Berkshire Asset Management increased its AbbVie (ABBV) stake by 1% in Q1 2026, buying an estimated $870K and bringing the position to 380,870 shares worth $82.8M. The position accounts for 3.55% of the portfolio, ranked #2.
Berkshire Asset Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $88.1M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Berkshire Asset Management held 380,870 shares of AbbVie worth $82.8M as of Q1 2026.
- Berkshire Asset Management bought 3,922 AbbVie shares in Q1 2026, an estimated $870K.
- AbbVie made up 3.55% of Berkshire Asset Management's portfolio in Q1 2026, its #2 holding.
- Berkshire Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Berkshire Asset Management's AbbVie position peaked at $88.1M in Q3 2025.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Berkshire Asset Management's 13F filing for Q1 2026, filed 11 May 2026.